IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.560
-0.170 (-9.83%)
Jun 2, 2026, 4:00 PM EDT - Market closed
IN8bio Employees
IN8bio had 17 employees as of December 31, 2025. The number of employees decreased by 1 or -5.56% compared to the previous year.
Employees
17
Change (1Y)
-1
Growth (1Y)
-5.56%
Revenue / Employee
n/a
Profits / Employee
-$1,116,471
Market Cap
15.36M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 17 | -1 | -5.56% |
| Dec 31, 2024 | 18 | -13 | -41.94% |
| Dec 31, 2023 | 31 | 5 | 19.23% |
| Dec 31, 2022 | 26 | 7 | 36.84% |
| Dec 31, 2021 | 19 | 5 | 35.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Quince Therapeutics | 38 |
| BioLineRx | 24 |
| Passage Bio | 24 |
| Citius Pharmaceuticals | 23 |
| NewcelX | 15 |
| Lipocine | 14 |
| Cocrystal Pharma | 10 |
| Lexaria Bioscience | 7 |
INAB News
- 23 hours ago - IN8bio Slides: Corporate presentation - Filings
- 1 day ago - IN8bio announces updated INB-200, INB-400 study data - TheFly
- 1 day ago - IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026 - GlobeNewsWire
- 12 days ago - IN8bio Transcript: R&D Day 2026 - Transcripts
- 12 days ago - IN8bio Slides: FY 2026 - Filings
- 15 days ago - IN8bio Registration statement: Registration filing - Filings
- 26 days ago - IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 26 days ago - IN8bio Quarterly report: Q1 2026 - Filings